Status:
WITHDRAWN
Determining the Reproductive Health of Men Post-COVID-19 Infection
Lead Sponsor:
Imperial College London
Conditions:
Infertility, Male
Testosterone Deficiency
Eligibility:
MALE
18-50 years
Brief Summary
Study rationale 1. An increasing proportion of the worldwide population is being infected with COVID-19. 2. There are ongoing and currently unanswered safety concerns about the effects of COVID-19 on...
Detailed Description
Male infertility results from impaired sperm function, and account for half of all infertility. Fertility services have been reported to cost £325M annually in the UK(4) (REF). Testosterone deficiency...
Eligibility Criteria
Inclusion
- Men 18-50 years of age
- Already attending hospital for another reason
- Low risk of prior COVID-19 infection(EITHER Negative positive COVID-19 PCR test result within last 4 weeks OR no history suggestive of COVID-19 illness)
- High risk of prior COVID-19 infection(EITHER Prior positive COVID-19 PCR test result OR history suggestive of COVID-19 illness)
Exclusion
- Men with current symptoms of COVID-19 infection
- Men currently self-isolating as per UK government advice for COVID-19 infection
- Needle-phobia
- Impaired ability to provide full consent to take part in the study
- History of co-morbidity likely to affect male reproductive function e.g. undescended testes, removal of testes, testicular cancer, drugs such as corticosteroids or testosterone therapy.
Key Trial Info
Start Date :
June 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 10 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04414904
Start Date
June 10 2020
End Date
June 10 2020
Last Update
November 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Channa Jayasena
London, Outside U.S./Canada, United Kingdom, W12 0HS